Programmed death‐ligand 1 expression and prognostic significance in bevacizumab treated ovarian cancer patients: Results from the phase IV MITO16A/MaNGO OV‐2 translational study

Programmed death‐ligand 1 expression and prognostic significance in bevacizumab treated ovarian cancer patients: Results from the phase IV MITO16A/MaNGO OV‐2 translational study

Saved in:
Bibliographic Details
Main Authors: Francesca Basso‐Valentina, Vincenzo Canzonieri, Rossella De Cecio, Laura Arenare, Domenica Lorusso, Sabrina Chiara Cecere, Eliana Pivetta, Daniela Russo, Annabella Di Mauro, Grazia Artioli, Anna Spina, Carmine De Angelis, Daniela Califano, Saverio Cinieri, Giosuè Scognamiglio, Vanda Salutari, Paolo Chiodini, Francesco Perrone, Sandro Pignata, Gustavo Baldassarre
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:Clinical and Translational Medicine
Online Access:https://doi.org/10.1002/ctm2.70373
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/ctm2.70373

Similar Items